Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Terminated Phase 2 Interventional

Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis

ClinicalTrials.gov ID: NCT01659138

Public ClinicalTrials.gov record NCT01659138. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 24, 2026, 12:25 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Primary Objective: To assess the efficacy of SAR339658 Secondary Objective: To assess the safety of SAR339658

Study identification

NCT ID
NCT01659138
Recruitment status
Terminated
Study type
Interventional
Phase
Phase 2
Lead sponsor
Sanofi
Industry
Enrollment
28 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 70 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Aug 2012 (Type not available)
Primary completion
Jun 2014 (Actual)
Completion
Apr 2016 (Actual)
Last update posted
Jul 13, 2016

2012 – 2016

United States locations

U.S. sites
25
U.S. states
18
U.S. cities
25
Facility City State ZIP Site status
Investigational Site Number 840065 Sun City Arizona 85351 —
Investigational Site Number 840059 Mission Hills California 91345 —
Investigational Site Number 840074 San Diego California 92114 —
Investigational Site Number 840061 Littleton Colorado 80120 —
Investigational Site Number 840003 Miami Florida 33136 —
Investigational Site Number 840008 Miramar Florida 33025 —
Investigational Site Number 840048 Winter Park Florida 32789 —
Investigational Site Number 840053 Savannah Georgia 31405 —
Investigational Site Number 840001 Chicago Illinois 60637 —
Investigational Site Number 840005 Oak Lawn Illinois 60453 —
Investigational Site Number 840078 Hammond Louisiana 70403 —
Investigational Site Number 840070 Rochester Hills Michigan 48098 —
Investigational Site Number 840060 Ocean Springs Mississippi 39564 —
Investigational Site Number 840024 Mexico Missouri 65265 —
Investigational Site Number 840051 Great Neck New York 11021 —
Investigational Site Number 840071 Rochester New York 14642 —
Investigational Site Number 840089 Winston-Salem North Carolina 27157-1071 —
Investigational Site Number 840046 Cincinnati Ohio 45219 —
Investigational Site Number 840045 Phoenixville Pennsylvania 19460 —
Investigational Site Number 840019 Pasadena Texas 77505 —
Investigational Site Number 840088 San Antonio Texas 78229 —
Investigational Site Number 840038 Sugar Land Texas 77479 —
Investigational Site Number 840068 Charlottesville Virginia 22908 —
Investigational Site Number 840034 Seattle Washington 98104-2499 —
Investigational Site Number 840064 Wauwatosa Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 16 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01659138, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jul 13, 2016 · Synced Oct 24, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT01659138 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →